Merck to initiate new clinical programme with lower dose of daily oral Islatravir in combination with Doravirine for HIV-1 treatment Read more
Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154 intra-nasal COVID vaccine Read more
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric Oxide nasal spray Read more
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years Read more